Michael Eden

Michael has over 20 years of management experience in overall financial & commercial strategy, fundraising and capital allocation, M&A transactions, investor relations, governance, and risk management. Michael is a Senior executive with vast experience in investing and managing high-growth technology companies, due diligence processes, post-acquisition integration, and active management and control over global subsidiaries. He has extensive knowledge of business, legal, and tax aspects relating to investments, management, and control of portfolio companies in different fields.

Michael serves as the Chief Financial Officer at Alon Medtech. Prior to joining Alon Medtech, Michael served as a Financial, Commercial, and Operational executive in leading high-growth technology companies such as Convergin, a provider of service broker platforms to mobile operators, acquired by Oracle; Hobart (Prof Shlomo Ben Haim’s investment group) specializing in active management of its health-care portfolio companies from startup stage through acquisition and IPOs; and Aura Investment a publicly traded investment company focused on early stage investments and active management of technology companies.